Abstract
The OXA-type β-lactamases are so named because of their oxacillin-hydrolyzing abilities. In this study we characterize an extended spectrum β-lactamase, designated OXA-4, produced by a clinical isolate of Pseudomonas aeruginosa. ESBL production was detected by double disk synergy test. The P. aeruginosa isolate was obtained from endotracheal suction tip of 84 years old male patient diagnosed with CVA and hypertension. ESBL producing OXA β-lactamases was detected by PCR with primers specific to the conserved regions of the coding genes. Iso electric focusing was done to confirm the significance, sequencing the amplified product was also done. In the phenotypic identification, the strain was highly resistant to third generation cephalosporins and also to imipenem. The PCR amplified product for OXA β-lactamase was viewed at 919 bp. The pI point for the same was identified at 7.2. With the help of sequencing the amplified OXA β-lactamase was identified as OXA-4 gene. Here we report P. aeruginosa producing OXA-4 ESBL for the first time in the Indian subcontinent.
Similar content being viewed by others
References
Philippon LN, Naas T, Bouthors AT, Barakett V, Nordamann P (1997) OXA-18, a class D clavulanic acid-inhibited extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother 41:2188–2195
Samaha-K-Foury JN, Araj GF (2003) Recent developments in β lactamases and extended spectrum P lactamases. BMJ 327:1209–1213
Brown S, Amyes S (2006) OXA β-lactamases in Acinetobacter: the story so far. J Antimicrobial Chemother 57:1–3
Mugnier P, Casin I, Bouthors AT, Collatz E (1998) Novel OXA-10-derived extended spectrum β-lactamses selected in vivo or in vitro. Antimicrob Agents Chemother 42:3113–3116
Danel F, Hall LM, Gur D, David ML (1998) OXA-16, a further extended spectrum variant of OXA-10 β-lactamase, from two Pseudomonas aeruginosa isolates. Antimicrob Agents Chemother 42:3117–3122
Clinical and Laboratory Standards Institute (CLSI) (2005) Performance standards for antimicrobial susceptibility testing. 15th informational supplement: M100-S15
Paterson DL, Rice LB, Bonomo RA (2001) Rapid method of extraction and analysis of extended-spectrum β-lactamases from clinical strains of Klebsiella pneumoniae. Clin Microbiol Infect 7:709–711
Kim J, Lim YM (2005) Prevalence of depressed AmpC mutants and extended spectrum β-lactamase producers among clinical isolates of Cirtrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12. J Clin Microbiol 43:2452–2455
Bert F, Juvin M, Ould-Hocine Z, Clarebout G, Keller E, Lambert N, et al (2005) Evaluation and updating of the Osiris expert system for identification of E. coli beta lactam resistance phenotypes. J Clin Microbiol 43(4):1846–1850
Subha A, Ananthan S (2002) Extended spectrum beta lactamase (ESBL) mediated resistance to third generation cephalosporins among Klebsiella pneumoniae in Chennai. Indian J Med Microbiol 20:92–95
Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK (2003) Prevalence of extended spectrum β-lactamase producing gram negative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol 52:421–425
Menon T, Bindu D, Kumar CPG, Nalini S, Thirunarayan MA (2006) Comparison of double disc and three dimensional methods to screen for ESBL producers in a tertiary care hospital. Indian J Med Microbiol 24:117–120
Taneja N, Rao P, Arora J, Dogra A (2008) Occurrence of ESBL & Amβ-C β-lactamases & susceptibility to newer antimicrobial agent in complicated UTI. Indian J Med Res 127:85–88
Matthew M, Hedges RW, Smith JT (1979) Types of β-lactamase determined by plasmids in Gram-negative bacteria. J Bacteriol 138:657–662
Medeiros AA, Cohenford M, Jacoby GA (1985) Five novel plasmid determined β-lactamases. Antimcrob Agents Chemother 27:715–719
Chmelnitsky I, Carmeli Y, Leavitt A, Schwaber MJ, Navon-Venezia S (2005) CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum beta-lactamases in multiple Escherichia coli clones isolated in Tel Aviv, Israel. Antimicrob Agents Chemother 49:4745–4750
Marumo K, Takeda A, Nakamura Y, Nakaya K (1999) Detection of OXA-4 β-lactamase in Pseudomonas aeruginosa isolates by genetic methods. J Antimicrob Chemother 43:187–193
Arduino SM, Catalano M, Orman BE, Roy PH, Centron D (2003) Molecular epidemiology of orf513-bearing class 1 integrons in multiresistant clinical isolates from Argentinean hospitals. Antimicrob Agents Chemother 47:3945–3949
Jeong JY, Yoon HJ, Kim ES, Lee Y, Choi SH (2005) Detection of qnr in clinical isolates of Escherichia coli from Korea. Antimicrob Agents Chemother 49:2522–2524
Sanschagrin F, Coutre F, Levesque RC (1995) Primary structure of OXA-3 and phylogeny of oxacillin-hydrolyzing class D β-lactamases. Antimicrob Agents Chemother 39:887–893
Bert F, Branger C, Lambert-Zechovsky N (2002) Identification of PSE and OXA β-lactamase in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J Antimicrob Chemother 50:11–18
Aubert D, Girlich D, Naas T, Nagarajar S, Nordamann P (2004) Functional and structural characterization of the genetic environment of an extended spectrum β-lactamase bla VEB gene from a Pseudomonas aeruginosa isolate obtained in India. Antimicrob Agents Chemother 48:3284–3290
Ahamed J, Kundu M (1999) SHV-11 molecular characterization of the SHV-11 β-lactamase of Shigella dysenteriae. Antimicrob Agents Chemother 43(8):2081–2083
Babypadmini S, Appalaraju B, Mani KR (2008) Detection of Enterobacteriaceae producing CTX-M extended spectrum beta lactamases from a tertiary care hospital in South India. Indian J Med Microbiol 26(2):163–166
Grover SS, Sharma M, Chattopadhya D, Kapoor H, Pasha ST, Singh G (2006) Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin. J Infect 53:279–288
Sekar B, Shwetha R, Arunagiri K, Menaka K, Lalitha P, Aparna V et al (2006) Detection and characterization of bla CTX-M gene by PCR-RFLP analysis among third generation cephalosporin resistant gram negative isolates. In: XXX National Congress of Indian Association of Medical Microbiologists. Microcon, p 27
Lal P, Kapil A, Das BK, Sood S (2007) Occurrence of TEM & SHV gene in extended spectrum β-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital. Indian J Med Res 125:173–178
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kingsley, S.A.J., Verghese, S. First Report of OXA-4, an ESBL Isolated from Pseudomonas aeruginosa a South Indian Strain. Indian J Microbiol 53, 308–314 (2013). https://doi.org/10.1007/s12088-012-0326-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12088-012-0326-3